| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12b31f64c482783c95736f015e158668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_133eda1c1e036af1d2994c6b6ed68f7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9148a393fd8f2df0f4fbd5942a6cbb32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27ed9426c852347847fb515020aacbc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d45899bdc69715f45f8611d2496c047 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-721 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2012-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dc1cc087739b04946d471487f040609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c3bedb945eae556c4fc33210ccc5b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdef1b2b6463b2b9f7442ec95a24d844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6394daa508bc745dc695d5be254eb80f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_707289bb80b8780b889eb2fe3412e475 |
| publicationDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012120130-A1 |
| titleOfInvention |
Methods to characterize patients suffering from hemolysis |
| abstract |
The present invention relates to methods for determining the risk of severe complications in hemolytic diseases. The present invention relates to a method for determining whether a patient suffering from sickle cell disease is at risk for a vaso-occlusive crisis comprising the steps consisting of i) determining the level of cell microparticles in a blood sample obtained from said patient and ii) determining the level of heme and/or hemoglobin contained in said cell microparticles. The present invention also relates to a method for a method the severe complication in hemolytic diseases comprising the steps consisting of i) determining the level of cell microparticles in a blood sample obtained from said patient and ii) determining the level of heme and/or hemoglobin contained in said cell microparticles. The present invention also relates to a method for preventing a vaso-occlusive crisis in a patient afflicted with by sickle cell disease comprising depleting the blood-borne microparticles laden in heme and hemoglobin from the blood of said patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022263407-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10894075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016513463-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017162722-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10139420-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021105137-A1 |
| priorityDate |
2011-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |